Mount Sinai Leaders Discuss Equity, the Impact of the Pandemic on Healthcare, and the Unprecedented Era and Increasing Interest of Psychedelics on Treating Mental Health at the 2021 Aspen Ideas Health and Aspen Ideas Festival
Reflections on the pandemic, developing innovative solutions to address inequities in health and medicine, and the use of psychedelic drugs to help treat psychiatric disorders are among the topics presented at Aspen Ideas Health and the Aspen Ideas Festival from June 27-July 1, 2021, in Aspen, Colorado.
- Thousands of individuals with the condition are likely undiagnosed.
- Study identifies underutilization of genetic testing as a major contributor to missed diagnoses.
- Findings underscore the growing importance of genetic testing as precision therapies advance toward patients.
Reflections on the pandemic, developing innovative solutions to address inequities in health and medicine, and the use of psychedelic drugs to help treat psychiatric disorders are among the topics presented at Aspen Ideas Health and the Aspen Ideas Festival from June 27-July 1, 2021, in Aspen, Colorado. Presented by the Aspen Institute and sponsored by the Mount Sinai Health System, the festival is a unique forum for the exchange of ideas.
“We are proud to once again participate in the Aspen Ideas festival where great ideas are advanced to bring about societal and systemic changes that benefit everyone,” said Kenneth L. Davis, MD, President and CEO of Mount Sinai Health System. “The exchange of bold ideas combined with a relentless pursuit of knowledge, understanding, and answers to the world’s most complex problems is one of many ways we are finding a way to healthier world for everyone.”
Unlike previous conferences, this year’s Aspen Ideas Festival will be a virtual gathering where a myriad of experts will share their ideas and insight on several topics. Built around the theme "American Futures," these sessions will focus on the future of democracy, identity, education, the search for meaning, our own mental health, and more.
In a panel titled “The Best Pandemic Big Ideas in Healthcare,” Executive Vice President of Diversity, Equity, and Inclusion, Mount Sinai Health System, Gary Butts, MD, will speak on rebuilding a healthcare system with inclusion at its core. From telehealth counseling to mobile clinics, Dr. Butts will weigh in these alternatives alongside other featured speakers. This panel will be broadcast on June 29 at 12pm MDT.
Rachel Yehuda, PhD, Director of the Center for the Study of Psychedelic Psychotherapy and Trauma, the Traumatic Stress Studies Division, and Professor of Psychiatry and Neuroscience, Icahn School of Medicine will discuss the use of psychedelics in a panel titled “The Shroom Boom and other Therapeutic Psychedelics for the Win.” Mental-health and substance-use disorders became more prevalent than ever during the pandemic, thus the wonder the clinical use of psychedelic drugs to help treat psychiatric disorders, including anxiety, depression, and PTSD, is fueling a research renaissance. Join Dr. Yehuda on July 1 at 5pm ET.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.